Published in Can Med Assoc J on August 01, 1983
The safety of blood transfusions. Can Fam Physician (1984) 0.75
Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol (1971) 3.68
Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science (1966) 2.70
Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%). Crit Care Med (1980) 1.20
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation (1982) 1.16
Oxygen transport in vivo by means of perfluorochemical preparations. N Engl J Med (1982) 1.09
A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther (1978) 1.05
Protective effect of Fluosol-DA in acute cerebral ischemia. Stroke (1982) 1.04
Appraisal of hemoglobin solution as a blood substitute. Surg Gynecol Obstet (1979) 0.98
Physiology and pharmacology of the coronary circulation and myocardium, particularly in relation to coronary artery disease. Am J Med (1969) 0.97
Fluorocarbons reduce myocardial ischemic damage after coronary occlusion. Science (1981) 0.96
Soluble dextran-hemoglobin complex as a potential blood substitute. Proc Natl Acad Sci U S A (1976) 0.93
Influence of fluorocarbon emulsions on hepatic metabolism in perfused rat liver. Am J Physiol (1973) 0.92
Characteristics of stroma-free hemoglobin prepared by crystallization. J Lab Clin Med (1977) 0.91
Transport of oxygen and carbon dioxide by hemoglobin-saline solution in the red cell-free primate. Surg Gynecol Obstet (1976) 0.91
Effects of red cell stroma-free hemoglobin solution on renal function in monkeys. J Appl Physiol (1970) 0.90
Large-volume preparation of pyridoxylated hemoglobin with high P50. J Surg Res (1981) 0.90
Hemoglobin solution: a potential oxygen transporting plasma volume expander. Fed Proc (1975) 0.89
Orthotopic rat liver transplantation after long-term preservation by continuous perfusion with fluorocarbon emulsion. Transplantation (1980) 0.89
The effect of altered hemoglobin-oxygen affinity on oxygen transport by hemoglobin solution. J Surg Res (1980) 0.87
Fluorocarbons: properties and syntheses. Fed Proc (1975) 0.86
Oxygen affinity of stroma free hemoglobin and its effect on tissue oxygenation. Bibl Anat (1977) 0.86
The oxyhemoglobin dissociation curve. Int Anesthesiol Clin (1981) 0.85
Effects of stroma-free hemoglobin solution on clearance rate and renal function. Surgery (1972) 0.84
Fluorocarbon and dextran hemodilution in myocardial ischemia. Can J Surg (1983) 0.83
Cross-linked hemoglobins as potential plasma protein extenders. Fed Proc (1975) 0.83
Hemoglobin solution as a plasma expander. Fed Proc (1975) 0.82
Modification of human hemoglobin with polyethylene glycol : a new candidate for blood substitute. Biochem Biophys Res Commun (1980) 0.82
Further studies with stroma-free hemoglobin solution. Ann Surg (1970) 0.81
Improved sodium and PAH transport in the isolated fluorocarbon-perfused rat kidney. Nephron (1978) 0.80
Extending the limits of hemodilution on cardiopulmonary bypass using stroma-free hemoglobin solution. J Thorac Cardiovasc Surg (1981) 0.79
The effect of hemodilution with stroma-free hemoglobin and dextran on collateral perfusion of ischemic myocardium in the dog. Am Heart J (1980) 0.79
Early deleterious hemorheologic changes following acute experimental coronary occlusion and salutary antihyperviscosity effect of hemodilution with stroma-free hemoglobin. Am Heart J (1982) 0.78
Fluosol-DA: an artificial blood for total cardiopulmonary bypass. Ann Thorac Surg (1981) 0.78
Morphologic effects following massive exchange transfusions with a stroma-free hemoglobin solution. I. Liver. Lab Invest (1978) 0.78
Reticuloendothelial system depression with hemolyzed blood and susceptibility to endotoxin shock and thermal injury. Circ Shock (1981) 0.78
Effects of potential blood substitutes (perfluorochemicals) on rat liver and spleen. Pflugers Arch (1980) 0.78
Comparison of acute cardiovascular effects and oxygen-supply following haemodilution with dextran, stroma-free haemoglobin solution and fluorocarbon suspension. Cardiovasc Res (1982) 0.78
The evaluation of synthetic oxygen carriers by perfusion of isolated rat liver. Acta Physiol Scand (1976) 0.77
Fluorocarbon emulsions: methodology to assess efficacy. Crit Care Med (1982) 0.77
Acute oxygen supply by infusion of hemoglobin solutions. Fed Proc (1975) 0.77
Cross-linked stroma-free polyhemoglobin as a potential blood substitute. Int J Artif Organs (1982) 0.77
Renal vascular effects of stroma and stroma-free hemoglobin. Surg Forum (1978) 0.76
The oxyhemoglobin dissociation curve in acute disease. Surg Clin North Am (1975) 0.76
Massive exchange transfusions with crystalline hemoglobin solution and subsequent replacement of hemoglobin and blood volume. Surg Gynecol Obstet (1980) 0.76
Artificial blood and the National Blood Policy. Fed Proc (1975) 0.76
Replacement of red cell functions by cyclic fluorocarbon emulsions. Prog Clin Biol Res (1981) 0.76
Fluorocarbon liver perfusion and fluorocarbon-glycine interaction. Fed Proc (1975) 0.76
High oxygen extraction combined with extensive oxygen consumption in the rat liver perfused with Fluosol-DA a new perfluoro compound emulsion. Pflugers Arch (1978) 0.76
Some functions of canine liver perfused ex vivo with bloodless fluorocarbon emulsion. Eur Surg Res (1979) 0.76
Blood policy and strategy: the American Blood Commission and the nation's blood resource. Hum Pathol (1980) 0.76
Improved oxygenation of ischemic myocardium by hemodilution with stroma-free hemoglobin solution. Chest (1979) 0.76
Tissue PO2 during reanimation with hemoglobin solutions. Eur Surg Res (1979) 0.76
Blood substitutes--a misnomer, nevertheless a promise. Can J Surg (1982) 0.76
Canadian Red Cross lecture. Current concepts of oxygen-transporting blood substitutes. Can J Surg (1982) 0.76
Artificial red blood cells. Trans Am Soc Artif Intern Organs (1980) 0.76
Hemoglobin solutions as red cell substitutes. Trans Am Soc Artif Intern Organs (1980) 0.76
Evaluation of hepatocellular and Kupffer cell function of the isolated guinea pig liver perfused by a fluorocarbon medium. Gastroenterology (1978) 0.76
Studies of anaesthesia in relation to hypertension. V. Adrenergic beta-receptor blockade. Br J Anaesth (1973) 1.28
Membrane changes induced by early myocardial ischemia in the dog. Can J Biochem (1980) 0.91
A phase I study of oxidized raffinose cross-linked human hemoglobin. Crit Care Med (2000) 0.90
Perfluorocarbon blood substitutes. Crit Rev Oncol Hematol (1987) 0.88
Fluorocarbon and dextran hemodilution in myocardial ischemia. Can J Surg (1983) 0.83
Myocardial blood flow and O2-supply following dextran-haemodilution and methaemoglobinaemia in the dog. Cardiovasc Res (1979) 0.82
Haemodynamic response following a 10% topload infusion of HemolinkTM in conscious, anaesthetized and treated spontaneously hypertensive rats. Transfus Med (2000) 0.79
A comparison of UW cold storage solution and St. Thomas' solution II: a 31P NMR and functional study of isolated porcine hearts. J Heart Lung Transplant (1992) 0.79
Mechanisms of the augmented secretion of vasopressin during haemorrhage in the vagotomized dog. J Physiol (1972) 0.79
The role of the aortic body chemoreceptors in the cardiac and respiratory responses to acute hypoxia in the anesthetized dog. Can J Physiol Pharmacol (1973) 0.79
The effect of hemodilution with stroma-free hemoglobin and dextran on collateral perfusion of ischemic myocardium in the dog. Am Heart J (1980) 0.79
Phospholipid composition of cardiac mitochondria and lysosomes in experimental myocardial ischemia in the dog. J Mol Cell Cardiol (1979) 0.78
Early deleterious hemorheologic changes following acute experimental coronary occlusion and salutary antihyperviscosity effect of hemodilution with stroma-free hemoglobin. Am Heart J (1982) 0.78
Comparison of acute cardiovascular effects and oxygen-supply following haemodilution with dextran, stroma-free haemoglobin solution and fluorocarbon suspension. Cardiovasc Res (1982) 0.78
The effect of high buffer cardioplegia and secondary cardioplegia on cardiac preservation and postischemic functional recovery: a 31P NMR and functional study in Langendorff perfused pig hearts. Can J Physiol Pharmacol (1991) 0.76
The effect of magnesium added to secondary cardioplegia on postischemic myocardial metabolism and contractile function--a 31P NMR spectroscopy and functional study in the isolated pig heart. Basic Res Cardiol (1992) 0.75
The effects of activated complement on myocardial performance in vitro. J Cardiovasc Surg (Torino) (1989) 0.75
Adenosine deaminase in stroma-free hemoglobin solution is not responsible for coronary vasoconstriction. Adv Exp Med Biol (1989) 0.75
Time course of myocardial bloodflow changes during healing of myocardial infarct in pigs. Can J Cardiol (1992) 0.75
Changes in the myocardial area at risk, infarct size, and collateral flow following nicardipine infusion in dogs. Can J Physiol Pharmacol (1991) 0.75
A convenient method for the determination of the solubility of hemoglobin and modified hemoglobins. Artif Cells Blood Substit Immobil Biotechnol (1994) 0.75
Systemic responses to SFHS-infusion in hemorrhaged dogs. Artif Cells Blood Substit Immobil Biotechnol (1996) 0.75
Effect of fluorocarbon exchange transfusion on myocardial infarcts. Am J Cardiol (1984) 0.75
Clearance of differentially labelled infused hemoglobin and polymerized hemoglobin from dog plasma and accumulation in urine and selected tissues. Biomater Artif Cells Immobilization Biotechnol (1992) 0.75
Oxygen binding of modified hemoglobins in solution. Adv Exp Med Biol (1989) 0.75
Stroma-free hemoglobin solutions prepared by crystallization and ultrafiltration methods; comparison of composition and coronary vasoconstrictor potency. Adv Exp Med Biol (1990) 0.75
Myocardial oxygen-supply during hemodilution with stroma-free hemoglobin and methemoglobin solutions. Prog Clin Biol Res (1978) 0.75
The effects of hemodilution with Hemolink upon hemodynamics and blood flow distribution in anesthetized dogs. Artif Cells Blood Substit Immobil Biotechnol (2001) 0.75
Relative rates of release and clearance of neurophysin and vasopressin in the dog. J Endocrinol (1972) 0.75
Resuscitation of bled dogs with pyridoxalated-polymerized hemoglobin solution. Biomater Artif Cells Immobilization Biotechnol (1992) 0.75
The cardiovascular effects of the surfactant pluronic F68 in anesthetized dogs. Adv Exp Med Biol (1990) 0.75
Does the area at risk of infarction change over time? Adv Exp Med Biol (1989) 0.75
Cardiac responsiveness to beta-adrenergic stimulation in experimental anemia. Can J Physiol Pharmacol (1976) 0.75
Fluorocarbons in the resuscitation of hemorrhage. Int Anesthesiol Clin (1985) 0.75
The effects of Ca++ on the preservation of myocardial energy and function with University of Wisconsin solution. A 31P nuclear magnetic resonance study of isolated blood perfused Langendorff pig hearts. J Heart Lung Transplant (1993) 0.75
The effect of propranolol on blood viscosity changes induced by experimental coronary occlusion. Can J Physiol Pharmacol (1984) 0.75
Large venous compliance in carboxyhemoglobinemia and hemodilutional anemia. Can J Physiol Pharmacol (1986) 0.75
Systemic hemodynamic and renal effects of unmodified human SFHS in dogs. Biomater Artif Cells Immobilization Biotechnol (1992) 0.75
The effects of hemodilution with Hemolink upon hemodynamics and blood flow distribution in anesthetized dogs. Artif Cells Blood Substit Immobil Biotechnol (2002) 0.75
Cardiovascular responses of hypertensive patients to induction of anaesthesia with Althesin. Postgrad Med J (1972) 0.75
Effect of hemodilution with dextran, stroma-free hemoglobin solution and fluosol-DA on experimental myocardial ischemia in the dog. Bibl Haematol (1981) 0.75
The role of amino groups in hemoglobin oxygen binding. Adv Exp Med Biol (1996) 0.75
The effect of dopexamine HCl upon collateral perfusion of the acutely ischemic myocardium in anesthetized dogs. Angiology (1990) 0.75